Skip to main content

Table 3 Strength of association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker prescription and COVID-19 outcome based on standardised criteria

From: Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality

  1. Legend: Table reports on the assessment of strength of association based on the Sir Bradford Hill criteria.37 The green and red coloured cells represent the criteria which were and were not met in each study, respectively. Use of inflammatory markers required the reporting of at least one inflammatory marker in relation to ACEI/ARB prescription. An effect on blood pressure required the reporting of systolic and/or diastolic blood pressure in relation to ACEI/ARB prescription. Although Reynolds et al. reported data regarding continuation of medication, no data on outcomes were reported